- Home
- IDYA vs FLOC Comparison
IDYA vs FLOC Comparison
Compare IDYA & FLOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- FLOC
- Stock Information
- Founded
- IDYA 2015
- FLOC 1996
- Country
- IDYA United States
- FLOC United States
- Employees
- IDYA N/A
- FLOC N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- FLOC Metal Fabrications
- Sector
- IDYA Health Care
- FLOC Industrials
- Exchange
- IDYA Nasdaq
- FLOC Nasdaq
- Market Cap
- IDYA 1.5B
- FLOC 1.7B
- IPO Year
- IDYA 2019
- FLOC 2025
- Fundamental
- Price
- IDYA $17.42
- FLOC $22.68
- Analyst Decision
- IDYA Strong Buy
- FLOC Strong Buy
- Analyst Count
- IDYA 13
- FLOC 5
- Target Price
- IDYA $53.58
- FLOC $33.60
- AVG Volume (30 Days)
- IDYA 1.4M
- FLOC 272.8K
- Earning Date
- IDYA 05-06-2025
- FLOC 05-13-2025
- Dividend Yield
- IDYA N/A
- FLOC 0.35%
- EPS Growth
- IDYA N/A
- FLOC N/A
- EPS
- IDYA N/A
- FLOC 10.41
- Revenue
- IDYA $7,000,000.00
- FLOC $535,278,000.00
- Revenue This Year
- IDYA $121.20
- FLOC $58.16
- Revenue Next Year
- IDYA $302.20
- FLOC $12.91
- P/E Ratio
- IDYA N/A
- FLOC $2.17
- Revenue Growth
- IDYA N/A
- FLOC 119.99
- 52 Week Low
- IDYA $13.45
- FLOC $16.69
- 52 Week High
- IDYA $44.42
- FLOC $30.50
- Technical
- Relative Strength Index (RSI)
- IDYA 43.87
- FLOC N/A
- Support Level
- IDYA $16.82
- FLOC N/A
- Resistance Level
- IDYA $21.43
- FLOC N/A
- Average True Range (ATR)
- IDYA 1.16
- FLOC 0.00
- MACD
- IDYA -0.16
- FLOC 0.00
- Stochastic Oscillator
- IDYA 13.02
- FLOC 0.00
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About FLOC Flowco Holdings Inc. Class A Common Stock
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.